1 min listen
Medicare Limitation of Aduhelm
FromNeurology Minute
ratings:
Length:
3 minutes
Released:
Jun 16, 2022
Format:
Podcast episode
Description
Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, discusses Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials. Read the full article discussed in this interview in the New York Times.
Released:
Jun 16, 2022
Format:
Podcast episode
Titles in the series (100)
Featured interview: MOG-IgG cell based assays: Featured interview: MOG-IgG cell based assays by Neurology Minute